Since December 2014, all federal Xarelto lawsuits have been consolidated in the Eastern District of Louisiana. Any federal lawsuits filed against Janssen Pharmaceuticals and Bayer AG, the manufacturers of Xarelto (rivaroxaban), would have been transferred to the Louisiana court for pre-trial proceedings. By moving all cases into one court, federal judges expect to increase efficiency by all parties involved.
Plaintiffs who have brought forth lawsuits against these manufacturers allege that they were not adequately warned about the potentially deadly side effects of Xarelto. Many have claimed that they experienced serious gastrointestinal bleeding, blood clots and brain hemorrhaging after taking the anticoagulant. By consolidating these similar cases, the hope is that litigants will be able to combine resources and present them in a more productive way. So far, the four following trial dates have been set for 2016: August 1, August 22, September 12, and October 17.
Bellwether trials such as these are proposed in order to set examples for future negotiations and settlements between both parties. Given the growing number of Xarelto cases being brought against Janseen and Bayer, these trial cases may be extremely helpful for other patients who wish to seek legal recourse and monetary compensation after being harmed by Xarelto.
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at firstname.lastname@example.org.